ADBiotech Co

ADBiotech Co Acquisitions (Net)

The Acquisitions (Net) of ADBiotech Co (179530.KQ) as of Nov 22, 2026 is 1.43 B KRW. In the previous year, Acquisitions (Net) was 2.70 B KRW — a change of -46.81% (lower).

Acquisitions (Net)

1.43 BKRW

YoY

-46.81%

Last updated:

Acquisitions (Net) of ADBiotech Co is 2024 1.43 B KRW. Acquisitions (Net) of ADBiotech Co was 2023 2.70 B KRW. It decreases by -46.81% lower compared to the previous year.

The ADBiotech Co Acquisitions (Net) history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Acquisitions (Net)
Date
Acquisitions (Net)
Jan 1, 2017
2.77 B KRW
Jan 1, 2018
889.77 M KRW
Jan 1, 2019
-379.90 M KRW
Jan 1, 2020
706.18 M KRW
Jan 1, 2021
-963.15 M KRW
Jan 1, 2022
-1.47 B KRW
Jan 1, 2023
2.70 B KRW
Jan 1, 2024
1.43 B KRW
The ADBiotech Co Acquisitions (Net) history
YEARAcquisitions (Net)YoY
1.43 BKRW-46.81%
2.70 BKRW-283.23%
-1.47 BKRW+52.84%
-963.15 MKRW-236.39%
706.18 MKRW-285.89%
-379.90 MKRW-142.70%
889.77 MKRW-67.87%
2.77 BKRW-4,311.19%
-65.76 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ADBiotech Co Stock analysis

What does ADBiotech Co do? ADbiotech Co., Ltd. generates revenue by manufacturing and selling chemical products across two distinct business segments. The Veterinary Medicine segment focuses on the production of antibiotics, anticoccidial agents, antimicrobial agents, nervous system agents, and synthetic antibacterial agents for use in pharmaceuticals and stockbreeding. This division serves customers in the animal health sector by providing essential medical compounds for livestock and other animals. The Supplementary Feed segment complements the core operations by manufacturing and selling functional supplementary feeds and other related products. This segment targets the stockbreeding and fisheries industries, offering nutritional solutions to enhance animal health and productivity. By combining these two segments, ADBiotech Co., Ltd. delivers a comprehensive range of chemical and feed-based solutions to its clients in Chuncheon, Gangwon-Do. ADBiotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ADBiotech Co stock

Acquisitions (Net) of ADBiotech Co is 1.43 B KRW in 2024.

Acquisitions (Net) of ADBiotech Co changed from 2.70 B KRW to 1.43 B KRW, representing a -46.81% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Acquisitions (Net) ADBiotech Co since 2006 – with annual values, charts, and detailed analysis.

Net acquisitions represent the cash spent on acquiring other businesses, net of divestitures. Large acquisitions can transform a company's growth trajectory.

Acquisitions (Net)'s KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Acquisitions (Net)'s ADBiotech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — ADBiotech Co

All Key Metrics — ADBiotech Co